Article: A-129 UNRAVELING ANTI-SPACER IMMUNOPROFILES OF ACQUIRED TTP PATIENTS USING ANTI-IDIOTYPIC ANTIBODIES

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer